Cart is empty Uncertainty in work schedules is associated with serious psychological distress among workers aged 18 to 64 years, according to an April data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Unawareness of memory decline tied to higher risk for progression
Unawareness, rather than heightened awareness, of memory decline is strongly associated with future clinical progression in older adults, according to a study published online April 25 in JAMA Network Open.
Chest e-tattoo boasts major improvements in heart monitoring
A new flexible, wearable medical device could provide a major boost in the fight against heart disease, the leading cause of death in the United States.
Discrimination at work could raise blood pressure
Dealing with discrimination at work—from bosses or coworkers—may be enough to send your blood pressure through the roof, a new study suggests.
New form of levodopa might improve parkinson’s care
An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show.
Esophageal cancer: Know the signs and reduce your risk
April is Esophageal Cancer Awareness Month, which makes this good time to learn the signs of esophageal cancer and what you can do to reduce your risk.
Under 40? What you should know about testicular cancer
April is Testicular Cancer Awareness Month, and for young men, it’s a good time to recognize the signs of testicular cancer. Approximately 1 of every 250 men in the U.S. will develop testicular cancer, with an average age of 33 at the time of diagnosis, according to the American Cancer Society.
Covid deaths down 95 percent this year: WHO
The WHO said Wednesday that COVID-19 deaths had dropped by 95 percent since the start of the year—but warned the virus was still on the move.
Study puts price tag on cost of menopause symptoms for women in the workplace
Menopause-related symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, joint aches and cognitive difficulties damage the quality of life for millions of women. They also can adversely affect women in the workplace. A newly published Mayo Clinic study puts numbers on that cost: an estimated $1.8 billion in lost work time and $28 billion when medical expenses are added, in the U.S. alone.
Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS
Researchers at Nagoya University in Japan have discovered a receptor, sigma-1 receptor, and a protein, ATAD3A, that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. Since there are drugs that specifically target the receptor, their findings suggest a new therapeutic strategy. They published the study in the journal Neurobiology of Disease.